Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Eli Lilly and Company
Inhibrx Biosciences, Inc
University of Pittsburgh
Intensity Therapeutics, Inc.
Carisma Therapeutics Inc
Advaxis, Inc.
Seagen Inc.
Fate Therapeutics